UPDATE 3-Roche's Tarceva extends lung cancer survival | Reuters
Links shared publicly online about this topic.
- 1,900total visits
UPDATE 3-Roche's Tarceva extends lung cancer survival | Reuters
* Study shows patients treated with Tarceva live longer
* Lung cancer most common cancer worldwide
* Positions drug well versus competitor
* Shares in U.S. partner OSI gain 6 pct, Roche down 0.2
View full resource at reuters.com
Tags: Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer Medication, Lung, Drug, Tarceva
Most Recently Shared on July 13, 2009 at 3:29 pm By:
Preliminary results from SATURN study show Tarceva extends OS in NSCLC says Roche, which plans to file for US approval. http://tiny.cc/WifSX
Advertisement
